![]() |
市场调查报告书
商品编码
1383332
2030 年工业生物技术市场预测:按类型、原材料、应用和地区分類的全球分析Industrial Biotechnology Market Forecasts to 2030 - Global Analysis By Type (Biochemical, Biofuel, Bioproduct and Other Types), Raw Material, Application and By Geography |
根据 Stratistics MRC 的数据,全球工业生物技术市场在预测期内预计将以 11.9% 的年复合成长率成长。
“工业生物技术市场”一词,也称为“白色生物技术”,描述了利用生物技术概念、设备和流程在工业规模上创造和生产产品。它利用细菌、酵母和酵素等活生物体来生产比传统化学製程更弹性、更环保、更实用的生物基产品、方法和解决方案。该市场包括农业、生物燃料、化学品、製药、食品和食品和饮料製造、环境管理和其他行业。生物技术领域未来的发展将对维护人类生命健康、提高生活品质、促进区域经济发展产生重大影响。
根据世界卫生组织(WHO)2022年2月发布的资料,癌症是全球头号死亡原因,2020年约占1,000万人死亡,占总死亡人数约6人。
基因工程、合成生物学和精确基因组编辑等生物技术方法和工具的发展进步已经改变了工业生物技术的能力。借助这些发展,微生物和酵素可以改进和优化,以生产各种生物基产品,如生物燃料、特殊化学品、生物製药和生物基材料。此外,透过提高生物系统的精确度和控制,生物技术人员可以创造具有改善的代谢途径的微生物。
开发生物技术製程、实验室和基础设施需要大量资金,这可能成为新业务企业和现有企业的障碍。生物技术产业经常需要最尖端科技、昂贵的专业设备和训练有素的工人。然而,开发和改进生物技术製程在研究和开发阶段可能需要大量的时间和资源。由于初始成本高昂,生物技术产品的商业化可能会被推迟,导致财务资源紧张。
近年来,消费者对环保、永续生产和道德生产产品的偏好发生了显着变化。这种思维转变正在推动对使用生物技术方法生产的产品的需求,这些产品本质上是永续的。此外,工业生物技术能够生产永续的生物基产品、生物燃料和特殊化学品,这些产品对环境的危害比传统产品小。消费者越来越多地寻求能够反映他们的价值观并解决对气候变迁和商品枯竭的担忧的替代品。
生物技术产业在一个复杂的法律规范内运作,其特点是不断变化的法规和严格的审查,因为生物技术工艺和产品可能对环境和人类健康产生负面影响。Masu。对于新的生物技术产品和工艺,获得法规的核准是一个耗时且成本高昂的过程,并且受到严格的安全法规的约束。然而,由于法规不确定性,公司可能不愿意在生物技术领域进行创新,这可能导致商业化和市场准入的延迟。
供应链中断和某些计划被推迟的事实是一个副作用,但进一步证明了生物技术在解决世界问题方面的重要性。对生物技术产品的需求正在增加,特别是在疫苗的生产和医疗保健行业。工业生物技术在 COVID-19 疫苗的快速生产中发挥了关键作用,展示了该行业的弹性和创新能力。然而,与疫情和当前经济状况有关的法规暂时损害了投资,并减缓了其他经济领域的一些生物技术业务的发展。
由于使用生物过程和生物体製造各种化学品的广泛应用,生化领域在预测期内占据了市场的最大份额。该部门对于推广环保和永续的製造方法至关重要。此外,化学品、特殊化合物和生物基材料(例如生物分解性塑胶)的生产需要使用微生物、酵素和其他生物催化剂来取代传统的化学合成过程。生物化学领域的应用遍及各个领域,包括製药、农业、食品和饮料和饮料以及化妆品。
食品废弃物领域预计将呈现良好的成长。在工业生物技术产业中,食品废弃物部分解决了最大限度减少食品废弃物和利用有机废弃物生产付加产品的重要问题。工业生物技术利用微生物和酵素过程来分解复杂的有机化合物,回收宝贵的资源,并减少食物废弃物处理对环境的影响。此外,透过从原本会被浪费的废物中创造出有价值的产品,这些绿色和永续的方法不仅可以减少食品废弃物造成的环境问题,而且可以支持循环经济,也将为您提供支持。
由于经济强劲发展、人口膨胀和环保意识不断增强,亚太地区占了最大份额。该地区对生物基材料产品的需求不断增加,特别是在农业、能源和医疗保健等关键产业。此外,政府对生物基公司和绿色技术的计画和法规支持也正在加速该地区工业生物技术的发展。在中国和印度等国家尤其如此,它们广泛利用研究和开发来提高其生物技术能力。
由于其对永续性的坚定承诺、严格的环境标准和完善的行业形势,欧洲预计将在预测期内实现盈利增长。随着该地区致力于最大限度地减少环境影响并转向环保的生物基解决方案,工业生物技术已成为关键的创新驱动力。Masu。此外,欧洲法规对生物技术创新的大力支持,特别是在製药、化学品和农业等领域,正在推动显着成长。
According to Stratistics MRC, the Global Industrial Biotechnology Market is expected to grow at a CAGR of 11.9% during the forecast period. The term "industrial biotechnology market," also referred to as "white biotechnology," describes the use of biotechnological concepts, instruments, and processes to create and produce products on an industrial scale. It involves utilizing living organisms, such as bacteria, yeast, and enzymes, to produce bio-based products, methods, and solutions that are more flexible, eco-friendly, and practical than conventional chemical-based processes. Agriculture, biofuels, chemicals, medicines, food and beverage production, environmental management, and other industries are included in the market. The preservation of human life and health, the enhancement of life quality, and the promotion of regional economic development will all be significantly impacted by the development of the biotechnology sector in the future.
According to the data published by the World Health Organization, in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.
The capabilities of industrial biotechnology have been transformed by the ongoing development of biotechnological methods and tools, such as genetic engineering, synthetic biology, and precise genome editing. With the help of these developments, microbes and enzymes can be modified and optimized to produce a variety of bio-based products, such as biofuels, specialty chemicals, biopharmaceuticals, and biobased materials. Additionally, biotechnologists can create microorganisms with improved metabolic pathways due to their increased precision and control over biological systems, which will increase yields and enable more efficient production.
Substantial capital is needed to develop biotechnological processes, laboratories, and infrastructure, which can be a barrier for both new and current businesses. Cutting-edge technologies, expensive specialized gear, and highly trained workers are frequently needed in the biotechnology industry. However, developing and refining biotechnological processes may require an enormous amount of time and resources during the research and development stage. The commercialization of biotech products may be delayed by these high initial expenditures, which may pose a burden on financial resources.
Consumer preferences for products that are environmentally friendly, sustainably made, and manufactured ethically have changed substantially in recent years. Due to this shift in perspective, there is a growing demand for products produced by biotechnological methods, which are by nature more environmentally friendly and sustainable. Furthermore, industrial biotechnology makes it possible to create sustainable bio-based products, biofuels, and specialty chemicals that are less harmful to the environment than their conventional counterparts. Consumers are increasingly seeking alternatives that reflect their values and address their worries about climate change and the depletion of commodities.
Due to the possible negative effects of biotechnological processes and products on the environment and human health, the biotech industry operates in a complex regulatory framework characterized by changing regulations and intense scrutiny. For novel biotech products or processes, obtaining regulatory approvals can be a time-consuming and expensive procedure with stringent safety regulations. However, companies may be reluctant to engage in biotechnological innovations because of regulatory uncertainty, which can cause delays in commercialization and accessibility to markets.
The fact that supply chains experienced disruption and certain projects were delayed is a side effect, but it further demonstrates the importance of biotechnology in tackling global problems. The need for biotechnology products has increased, particularly in the creation of vaccines and the healthcare industry. A crucial role in the rapid creation of COVID-19 vaccines was played by industrial biotechnology, demonstrating the sector's flexibility and capacity for innovation. Restrictions associated with the epidemic and the current condition of the economy, however, have temporarily harmed investments and slowed down the development of several biotech businesses in other sectors of the economy.
Due to the wide range of applications that use biological processes and organisms to manufacture various chemicals, the biochemical segment held the largest share of the market over the forecast period. This sector is essential for promoting environmentally friendly and sustainable manufacturing methods. Moreover, in order to produce chemicals, specialty compounds, and bio-based materials like biodegradable plastics, it entails replacing traditional chemical synthesis processes with the use of microbes, enzymes, and other biocatalysts. Applications of the biochemical sector can be found in a variety of fields, including pharmaceuticals, agriculture, food and beverage, and cosmetics.
Food Waste segment is anticipated to witness lucrative growth. Within the industrial biotechnology industry, the food waste segment addresses the crucial problem of minimizing food waste and utilizing organic waste materials to produce products with added value. Industrial biotechnology uses microbes and enzymatic processes to break down complex organic compounds, recover valuable resources, and reduce the environmental impact of disposing of food waste. Moreover, by creating valuable products from garbage that would otherwise go to waste, these environmentally friendly and sustainable methods not only reduce the environmental problems caused by food waste but also support the circular economy.
Due to its robust economic development, expanding population, and rising awareness of the environment, the Asia-Pacific area accounted for the largest share. Particularly in important industries such as agriculture, energy, and healthcare, the region has experienced an increase in demand for products made from bio-based materials. Furthermore, government programs and regulatory assistance for bio-based companies and green technologies have also accelerated the development of industrial biotechnology in the area. This is especially apparent in nations like China and India, which have extensively used R&D to improve their biotechnology abilities.
Due to its strong dedication to sustainability, strict environmental standards, and well-established industrial landscape, Europe is predicted to experience profitable growth during the projected period of time. The region's emphasis on minimizing its environmental impact and transitioning to eco-friendly, bio-based solutions has elevated industrial biotechnology to the position of a major innovation driver. Moreover, significant growth has been facilitated by Europe's solid regulatory support for biotechnological innovations, particularly in areas like pharmaceuticals, chemicals, and agriculture.
Some of the key players in Industrial Biotechnology market include: BASF SE, Codexis, Inc., Fermentalg, Borregaard AS, Gevo, Inc., Global Bioenergies, Evolva, Amyris, Inc., Novozymes and Deinove.
In October 2023, BASF invests a high double-digit million euro amount in a new fermentation plant for biological and biotechnology-based crop protection products at its Ludwigshafen site. The plant will manufacture products that bring value to farmers including biological fungicides and biological seed treatment. BASF also plans to utilize the plant to produce the main building block of Inscalis®, a novel insecticide derived from a fungal strain.
In June 2023, The German chemicals giant has announced it would increase its global alkyl polyglucosides (APGs) production capacity with two expansions at its sites in Bangpakong, Thailand, and Cincinnati, Ohio.